6-triazolopyridazine sulfanyl benzothiazole derivatives as MET inhibitors
US9321777B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2015 |
| Grant date | Apr 26, 2016 |
| Priority date | — |
| Expiry date | Jun 4, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to compounds of formula (I):wherein , A, W, X, and Ra are as defined in the disclosure, and salts thereof, and to pharmaceutical compositions comprising said compounds, to processes for preparing them, and to their use as medicaments, in particular as MET inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.